| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 11/16/1989 | WO1989010749A1 Cosmetic or dermatological composition, in particular with slimming or anti-cellulitic action, containing free or liposomal cola extracts |
| 11/16/1989 | WO1989010746A2 Blood substitute |
| 11/16/1989 | WO1989010745A1 Compositions and in situ methods for forming films on body tissue |
| 11/16/1989 | WO1989010743A1 Long lasting composition of propafenone and quinidine for treatment of cardiac conditions |
| 11/16/1989 | WO1989010740A1 Buccal local anaesthetic |
| 11/16/1989 | WO1989010739A1 Hydroxyalkyl cyclodextrin-antifungal polyene antibiotics complexes |
| 11/16/1989 | DE3815473A1 System of active substances for lipid exchange with target structures |
| 11/15/1989 | EP0342121A2 Anti-allergic extract |
| 11/15/1989 | EP0342106A1 Controlled release tablets containing water soluble dilatizem salts and preparation thereof |
| 11/15/1989 | EP0342100A1 Cosmetic or dermatological slimming or anti-cellulitis composition containing cola extracts, free or into liposomes |
| 11/15/1989 | EP0341774A1 Pharmaceutical solutions of triamterene |
| 11/15/1989 | EP0341661A2 Peptide-drug compositions containing alpha-aminoboronic acid derivatives |
| 11/15/1989 | EP0341584A1 Soft capsular preparation of sodium picosulfate |
| 11/15/1989 | EP0341311A1 Hexapeptide and pharmaceutical preparation based thereon for curing erosive-ulcerous injuries to the digestive tract |
| 11/15/1989 | EP0341291A1 Controlled administration of beneficial agent to blood. |
| 11/15/1989 | CN1037085A Process for preparation of dysmenorrhea meprobamate |
| 11/15/1989 | CN1037082A Multi-layer granule |
| 11/14/1989 | US4880835 Oral liquid pharmaceutical compositions of sulindac |
| 11/14/1989 | US4880830 Slow release formulation |
| 11/14/1989 | US4880823 Injection of nicardinpine hydrochloride and process for the production thereof |
| 11/14/1989 | US4880813 Method of treatment for allergic rhinitis |
| 11/14/1989 | US4880794 Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration |
| 11/14/1989 | US4880791 Blood disorders |
| 11/14/1989 | US4880785 Viricides |
| 11/14/1989 | US4880636 Storage stability, triacetin plasticizers |
| 11/14/1989 | US4880635 Dehydrated liposomes |
| 11/14/1989 | US4880634 Colloids |
| 11/14/1989 | US4880633 Transdermal drug delivery system |
| 11/14/1989 | US4880631 Controlled porosity osmotic pump |
| 11/14/1989 | US4880629 Dialytic solution for peritoneal dialysis |
| 11/14/1989 | US4880628 Sustained release composition |
| 11/14/1989 | US4880623 Process for the preparation of solid nifedipine formulations of high bioavailability and with sustained effect, and formulations thus obtained |
| 11/14/1989 | US4880622 Water-soluble phosphazene polymers having pharmacological applications |
| 11/14/1989 | US4880617 Lattice-entrapped composition |
| 11/14/1989 | US4880585 Continuous method of tableting |
| 11/14/1989 | US4880563 Cosmetic lotions |
| 11/14/1989 | US4880416 Dermal bandage and dermal preparation |
| 11/14/1989 | CA1262863A1 Fusogenic liposomes and method of making same |
| 11/14/1989 | CA1262847A1 Silicon implant devices |
| 11/09/1989 | DE3912685A1 Pharazeutische praeparation, enthaltend felbinac Pharazeutische preparation containing felbinac |
| 11/09/1989 | DE3912292A1 Azelastine-containing pharmaceuticals with controlled release of active substance |
| 11/08/1989 | EP0341202A1 Transdermal monolithic systems |
| 11/08/1989 | EP0340662A1 Solid, water-soluble, pharmaceutical composition containing acetylcysteine |
| 11/08/1989 | EP0340307A1 Composition of polymer diffusion matrix for transdermally introducing pharmaceutical substances |
| 11/08/1989 | EP0340289A1 Liquid ibuprofen compositions and methods of making them |
| 11/07/1989 | US4879308 Aqueous nitroglycerin injection and manufacturing process |
| 11/07/1989 | US4879304 Ophthalmic compositions and process for preparing |
| 11/07/1989 | US4879303 Besylate salt of amlodipine; antiischemic, hypotensive |
| 11/07/1989 | US4879297 Transdermal drug delivery |
| 11/07/1989 | US4879294 Opthalmic composition |
| 11/07/1989 | US4879286 Anticarcinogenic agents |
| 11/07/1989 | US4879274 External medication for skin |
| 11/07/1989 | US4879272 On walls of container |
| 11/07/1989 | US4879119 Patch |
| 11/07/1989 | US4879118 Antipruritic |
| 11/07/1989 | US4879108 Chewable |
| 11/07/1989 | US4879062 Preparation of a gel having gas transporting capability |
| 11/07/1989 | US4878905 Gastrointestinal module: a nonsurgical implant |
| 11/07/1989 | US4878892 Electrolytic transdermal delivery of polypeptides |
| 11/07/1989 | CA1262686A1 Composition to alleviate nausea and vomitting |
| 11/07/1989 | CA1262682A1 Treatment of biological and pharmaceutical products adsorbed on a solid phase with virus and pyrogen inactivating agents |
| 11/02/1989 | WO1989010186A1 Lipid composition having enough safety and strong surface activity |
| 11/02/1989 | WO1989010142A1 Interaction system comprising a surfactant-stabilized disperse aqueous phase containing an antibody or antibody fragment |
| 11/02/1989 | WO1989010132A1 Porous particles in preparations involving immiscible phases |
| 11/02/1989 | WO1989010129A1 Pharmaceutical composition containing deoxyribonucleosides for wound healing |
| 11/02/1989 | WO1989010124A1 Antidote for organic phosphorus compound poisoning |
| 11/02/1989 | WO1989010118A1 Improved emulsions of highly fluorinated organic compounds |
| 11/02/1989 | WO1989010117A1 Controlled release of active ingredients from capsules having a salt sensitive shell material |
| 11/02/1989 | WO1989010116A1 Gelcores |
| 11/02/1989 | WO1989010113A1 Antimicrobial composition with long-term activity |
| 11/02/1989 | WO1989010108A1 Laminated composite for transdermal administration of fentanyl |
| 11/02/1989 | EP0340105A1 Diltiazem microspheres, process for producing, and sustained pharmaceutical release compositions containing them |
| 11/02/1989 | EP0340079A1 Viscoelastic isotropic material based on water, fluorinated surfactants, and fluorinated oils, their preparation and their use in different fields, such as the optical, pharmacological and electrodynamical field |
| 11/02/1989 | EP0339811A2 Aqueous based pharmaceutical coating composition for dosage forms |
| 11/02/1989 | EP0339607A2 Composition for repair of cartilage and bone and method for their preparation as skeletal tissue implant |
| 11/02/1989 | EP0339555A2 Water soluble preparations of coccidiostatics |
| 11/02/1989 | EP0339508A1 Mouth-soluble pharmaceutical compositions containing acetylcysteine |
| 11/02/1989 | EP0339506A1 Oral osmotic system with a modified adhesion of the membrane to the core |
| 11/02/1989 | EP0339465A2 Antibacterial composition for oral administration |
| 11/02/1989 | EP0339420A2 Sustained-release DHP preparation |
| 11/02/1989 | EP0339176A1 Suppository containing a non-steroidal anti-inflammatory medicament |
| 11/02/1989 | EP0339144A1 A method for the preparation of microcapsules |
| 10/31/1989 | US4877883 Substituted pyrazoles |
| 10/31/1989 | US4877781 Tixocortol pivalate, ephedrine sulfate, pramoxine hydrochloride; antiinflammatory agents for hemorrhoids |
| 10/31/1989 | US4877621 Styrene-vinylpyridine copolymer; fatty acids, alcohols, or esters; stability |
| 10/31/1989 | US4877620 Ibuprofen-containing medicament |
| 10/31/1989 | US4877619 Liposomal vesicles for intraperitoneal administration of therapeutic agents |
| 10/31/1989 | US4877618 Transdermal drug delivery device |
| 10/31/1989 | US4877608 Sodiuum chloride and-or potassium chloride, lysine hydrochloride, and histidine |
| 10/31/1989 | US4877606 Freeze dried, stable aqueous dispersion of drug |
| 10/31/1989 | US4877561 Dispersing drug and phospholipid, gelating by adding volatile solvent, evaporating |
| 10/31/1989 | US4876802 Process and means for the heat treatment of powdery or granulate material |
| 10/31/1989 | CA1262524A1 Release devices |
| 10/25/1989 | EP0338971A1 Process for preparing liposomes and/or biological cells containing ingredients, and their use |
| 10/25/1989 | EP0338861A2 Antacid compositions with prolonged gastric residence time |
| 10/25/1989 | EP0338820A2 Heat sealable membrane for transdermal drug release |
| 10/25/1989 | EP0338819A2 Matrix for transdermal drug release |
| 10/25/1989 | EP0338679A2 Tumour necrosis factor in the treatment of bladder cancer |
| 10/25/1989 | EP0338670A2 Pharmaceutical Compositions |
| 10/25/1989 | EP0338507A2 Use of mabuterol and related compounds for intraocular pressure adjustment |